Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

GW Pharma, Otsuka Satvex Deal Terminated

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:BioPharma

As a result, GW has now reacquired full ownership of the development and commercialization rights to the product in the U.S. market. Source: BioSpace

Continue ReadingGW Pharma, Otsuka Satvex Deal Terminated

Daichi Sankyo Abandons Deal With Nektar Therapeutics After Drug Tanks in Europe

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:BioPharma

Daiichi Sankyo informed Nektar that it was terminating a collaboration and licensing deal, effective Feb. 4, 2018. Source: BioSpace

Continue ReadingDaichi Sankyo Abandons Deal With Nektar Therapeutics After Drug Tanks in Europe

Roche Gets in on Bay Area Allakos' $100M Funding Round

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:BioPharma

The round was led by NEA and included Redmile Group, Partner Fund Management, Rock Springs Capital, LifeSci Venture Partners, Samsara BioCapital, and a large institutional investor. Source: BioSpace

Continue ReadingRoche Gets in on Bay Area Allakos' $100M Funding Round

Why Bluebird Bio Investors Aren't Singing the Blues

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:BioPharma

bluebird bio stock has been on an upswing for most of the year, having recently taken a spike after positive news at the ASH Annual Meeting. Source: BioSpace

Continue ReadingWhy Bluebird Bio Investors Aren't Singing the Blues

Why Pfizer's 2017 Was Mediocre at Best

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:BioPharma

Pfizer's 2017 wasn't horrible. Just ho-hum. Source: BioSpace

Continue ReadingWhy Pfizer's 2017 Was Mediocre at Best

Besties Regeneron, Sanofi Show Off Phase II Skin Cancer Data

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:BioPharma

The positive results are spurring the companies to begin seeking approval for the checkpoint inhibitor. Source: BioSpace

Continue ReadingBesties Regeneron, Sanofi Show Off Phase II Skin Cancer Data

Korean Manufacturer Warned for GMP, Quality Violations

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:Drug Industry Daily

The FDA issued a warning to a Korean drugmaker for significant current good manufacturing practice violations and the lack of an adequate quality control unit. Source: Drug Industry Daily

Continue ReadingKorean Manufacturer Warned for GMP, Quality Violations

ANSM Creates New Unit to Handle Early Stage Clinical Trials

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:Drug Industry Daily

France’s Agency for the Safety of Health Products has established a unit dedicated to overseeing early phase clinical trials. Source: Drug Industry Daily

Continue ReadingANSM Creates New Unit to Handle Early Stage Clinical Trials

Whistleblower Says Drugmaker Fired Him for Raising Concerns About CMO

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:Drug Industry Daily

A newly unsealed whistleblower lawsuit claims Regeneron fired a manager for raising concerns about the drugmaker’s manufacturing process. Source: Drug Industry Daily

Continue ReadingWhistleblower Says Drugmaker Fired Him for Raising Concerns About CMO

FDA Spells Out ‘Refusal to File’ Scenarios for NDAs and BLAs

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:Drug Industry Daily

The FDA issued draft guidance on when CDER may refuse to file new drug applications and biologics license applications, outlining errors or omissions that can lead them to classify the…

Continue ReadingFDA Spells Out ‘Refusal to File’ Scenarios for NDAs and BLAs
  • Go to the previous page
  • 1
  • …
  • 229
  • 230
  • 231
  • 232
  • 233
  • 234
  • 235
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.